In a large public-private project, supported by 110 million euros by the IMI, a large consortium of researchers will search for biomarkers with which people with autism can be divided into clear subgroups.Such stratification increases the chance of effective treatments. The Radboud UMC is also involved in the huge project. In 2012 the large European autism research EU-AIMS started. This abbreviation stands for European Autism Interventions - a Multicenter Study for Developing New Medications. The project, which ended at the end of March of this year, has immediately received a successor: AIMS-2. This new project builds on the results that the first program has produced.
Public-private projectThe main applicant for AIMS-2 is the British King's College in London, but the researchers at Donders Institute and Radboudumc are also important partners in the project. Professor of psychiatry Jan Buitelaar is co-leader of clinical studies, Professor of Statistical Imaging Neuroscience Christian Beckmann leads the development of new statistical techniques and databases. The public-private project has been awarded by the European IMI, the Innovative Medicines Initiative. With the pharmaceutical companies that participate, the research institutes received a total of 110 million euros to unravel the Autism Spectrum Disorder (AAS) in detail and on that basis develop medication for the various subgroups that fall under ASD.
Related news items
Cognitive behavioral therapy effective in MD1 New treatment option for complex disease21 September 2018
Treatment with cognitive behavioral therapy helps patients with myotonic dystrophy type 1 in improving their physical abilities and social participation. This is the result of a survey of more than 250 patients in four European countries.read more
Rebecca Halbach receives poster prize at EMBO conference20 September 2018
Rebecca Halbach, theme Infectious diseases and global health, has received a poster prize at the EMBO Workshop ‘piRNAs and PIWI proteins’, held in Montpellier, France.read more
Netherlands X-omics Initiative: Consortium kick off meeting20 September 2018
The Netherlands X-omics Initiative had their consortium kick-off meeting. Consortium members from the Dutch partners involved gathered to get to know each other and to determine the next steps to start up the project.read more
Successful teamwork between Neurology and Human Genetics leads to identification of two new ataxia genes19 September 2018
Thanks to close cooperation between Bart van de Warrenburg (Neurology) and Erik-Jan Kamsteeg (Humans Genetics) two new genes involved in movement disorders were identified. The genes are relevant for autosomal recessive cerebellar ataxia.read more
Rectal cancer staging using MRI with endorectal filling19 September 2018
In the British Journal of Radiology Rutger Stijns and colleagues, showed that using MRI with endorectal filling did not lead to an improved rectal cancer staging and that it has the potential to influence the distance to a key anatomical landmark.read more
Low risk of progression in persistent non-dysplastic Barrett’s esophagus19 September 2018
In Clinical Gastroenterology and Hepatology Peter Siersema and Yonne Peters showed that patients with stable persistence of non-dysplastic Barrett’s esophagus have a low risk of malignant progression and may not benefit from routine endoscopic surveillance.read more